Final clinical flashcards
Classes of antiarrhythmic drugs (5)
- Na+ blocking, membrane stabilising
- Beta blockers
- K+ channel blocking
- Non dihydropyridine CCBS
- Others
Class 1 antiarrhythmic drugs (3)
- Na+ blocking
- E.g lidocaine, propenafone, flecanide (split into further classifications)
- Contraindicated in asthma, copd, structural/IHD
Class 2 antiarrhythmic drugs (2)
- Beta blockers
2. Cardiospecific beta blockers: acebutol, atenolol, bisoprolol metoprolol, nebevilol
Class 3 antiarrhyhmic drugs (4)
- K+ channel blockers
- E.g. amiodarone, dronedarone, sotalol
- Amiodarone is 4 weeks before and 12 months after electrical cardioversion to increase success
- Dronedarone is associated with hepatotoxic and HF side effects
Class 4 antiarrhythmic drugs (4)
- Rate limiting CCBS (non-dihydropyridine)
- E.g verapamil, diltiazem
- Avoid verapamil in beta blocker pts (increased risk of hypotension and asystole)
- Diltiazem is unlicesned for arrhythmia
Class 5 antiarrhythmic drugs (3)
- Other
- E.g adenosine and digoxin
- Digoxin is only used if sedentary + AF+ congestive heart failure altogether
Maintenance treatment AF (2)
- Rate control is 1st line, rhythm control is 2nd line
2. Anticoagulation needed for stroke prophylaxis?
Rate control for AF (3)
- Beta blocker
- Rate limiting CCB
- Beta blocker+rate limiting CCB/ digoxin
Rhythm control for AF (2)
- Beta blocker
2. Sotalol/ amiodarone/ flecainide, propafenone, dronedarone
How to assess stroke and bleed risk in AF
- CHADsVASc and HASBLED
- Anticoagulate if chadvasc is 2 or more
- Consider further if HASBLED high risk of bleed 3 or more
CHADsVASc risk factors
Congestive HF HTN Age (75+) -2 Diabetes Stroke - 2 Vascular disease Age (65-74) Sex
HAS BLED risk factors
HTN Liver disease (bilirubin 2x normal and ALT etc 3x normla) Renal impairment Stroke history Bleeding history Labile INR Elderly Drugs (inc etoh)
If anticoagulation indicated in AF (as per chadvasc and hasbled)
If new onset give parenteral
If diagnosed, warfarin or DOAC
Amiodarone main indication
Treatment of arrhythmias, particularly when other drugs are ineffective or contraindicated
Amiodarone mode of action
K+ channel blocker. Prolongs the repolarization of the heart during phase 3 of the cardiac action potential, prolonging the length of the action potential.
Amiodarone side effects (8)
- Optic neuropathy (may cause blindness). Stop immediately if signs of impaired vision.
- Corneal microdeposits. May reverse on stopping. Cause night time glares when driving.
- Grey slated skin on exposure to sunlight (use wide spectrum, high SPF sunscreen for months after stopping)
- Phototoxicity.
- Peripheral neuropathy
- Pulmonary fibrosis, pneumonitis (SOB, cough)
- Hepatotoxicity. Watch out for nausea, vomiting, malaise, jaundice, itching, bruising, abdo pain.
- Thyroid issues (if hyper stop and give carbimazole, if hypo can continue and give levo)
Also commonly causes constpiatiom, movement disorders, sleep disorders, altered taste, vomiting
Amiodarone monitoring (5)
- K+ beforehand as may cause hypokalemia
- Chest x ray before
- TFTs before and then 6 monthly
- LFTs before and 6 monthly
- Annual eye tests (not in BNF)
+HR and BP as can cause hypotension and bradycardia
Amiodarone interactions (4)
Remember has a half life of around 50 days
- Enzyme inhibitors can increase the concentration of amiodarone e.g. grapefruit
- Amiodarone itself is an enyzme INHIBITOR and so increases the concentration of digoxin, warfarin and phenytoin (must half dose)
- Amiodarone increases the risk of myopathy and so avoid where possible. Manufacturer advises for simvastatin max 20mg OD with amiodarone/ amlodipine/ ranolazine/ verapamil/ diltiazem. (note max 40mg max for ticagrelor+simvastatin)
- Beta blockers and rate limiting CCBS can cause bradycardia, AV block and myocardial depression
- QT prolongation. Quinolone, macrolides, TCAs, SSRIs, lithium, quinine, hydroxychloroquinie, anti-malarials, antipsychotics
Drugs which prolong QT and therefore interact with amiodarone (9)
- TCAs
- SSRIs
- Lithium
- Quinine
- Quinolones
- Macrolides
- Hydroxychloroquinine
- Antimalarials
- Antipsychotics
Amiodarone: other
MHRA/CHM advice: Sofosbuvir with daclatasvir; sofosbuvir and ledipasvir (May 2015); simeprevir with sofosbuvir (August 2015): risk of severe bradycardia and heart block when taken with amiodarone (avoid but if necessary, counsel on signs of bradycardia and heart block)
Indications for digoxin (2)
- Maintenance for AF/ flutter (125-250)
2. Worsening/ severe heart failure in sinus rhythm (62.5-125)
Mode of action of digoxin
Digoxin induces an increase in intracellular sodium that will drive an influx of calcium in the heart and cause an increase in contractility. Cardiac output increases (positive inotrope) with a subsequent decrease in ventricular filling pressures. AV Node Inhibition: Digoxin has vagomimetic effects on the AV node. By stimulating the parasympathetic nervous system, it slows electrical conduction in the atrioventricular node, therefore, decreases the heart rate (negative chronotrope)
Bioavailability of digoxin preparations
Elixir 65%
Tablet 90%
IV 100%
BNF: “when switching from IV to oral route may need to increase dose by 20-33% to maintain the same plasma digoxin concentration)
Causes of digoxin toxiicty (4)
- Hypokalemia
- Hypomagnemesia
- Hypercalcemia
- Renal impairment
Signs of digoxin toxiicty
- Bradycardia/ heart block
- N+V, diarrhoea, abdo pain
- Blurred/ yellow vision
- Confusion/ delirium
- Rash
Digoxin - interactions (4)
- Increased Cp due to presence of enzyme inhibitors
- Decreased Cp in response to enzyme inducers
- Reduced renal excretio may lead to toxicity - watch out for NSAIDs, ACEI/ ARBs
- Hypokalemia predisposes, so avoid diuretics, B2 agonists, steroids, K+sparing diuretics
Drugs which may cause hypokalemia and therefore precipitate digoixin toxicity (4)
- Diuretics (loops eg furosemide and thiazides eg bendro)
- B2 agonists
- Steroids
- Theophylline
Target K+ if patient is on digoixin
4.5mmol/L.
If less than this give either K+ supplements or K+ sparing diuretics (eg spironolactone, eplerenone)
Drugs which precipitate digoxin toxicity
Anything that causes hypokalemia (loop+thiazide diuretics, asthma drugs)
Enzyme inhibitors as they increase the level of digoxin (eg amiodarone)
Drugs which cause renal failure
Drugs which cause hypomagnemesia
Drugs which cause hypercalcemia
Types of VTE (2)
- DVT
2. PE (detached blood clot travels to lungs and blocks pulmonary artery)
Risk factors for VTE (8)
Malignancy History of VTE Thrombophilic disorder Pregnancy COC/ HRT Immobility Age >60 BMI>60
Risk factors for bleed (5)
Systolic HTN Anticoagulants Bleeding disorders Acute stroke Thrombocytopenia
Prophylaxis of VTE: treatment options
Mechanical prophylaxis (TEDs, IVC) LMWH+UFH preferred in renal impairment Fondaparinux is another option in certain cases Apixaban+ rivaroxaban+ dabigatran are for post knee/ hip replacement Edoxaban is for recurrent VTE
Prophylaxis of VTE: duration of prophylaxis
5-7 days post surgery /sufficient mobility
extended if hip/ knee
28 day if cancer related abdo surgery/ pelvis surgery- major
Treatment of VTE (non pregnant)
Apixaban or rivaroxaban
LMWH or UFH (monitor APTT) in renal failure
Fondaparinux
LMWH for 5 days» then edoxaban/ dabigatran
LMWH+ warfarin for 5 days or until INR 2.0 or more for 2 consecutive readings
Treatment of VTE in pregnancy
LMWH preferred
Measure antixa activity routinely if extremes of body weight
Anticoagulants
Parenteral (UFH, LMWH, fondaparinux)
Oral (DOAC, warfarin)
The heparins
UFH - activates antithrombin. short acting. good if high risk of bleed or renal impairment. Must monitor APTT.
LMWH - anti xa inhibitor. longer acting. used in pregnancy. lower risk of osteoporosis and HIT.
Heparins - side effects (4)
- Haemorrhage (stop heparingive protamine)
- Hyperkalemia (as inhibits aldosterone) - monitor before treatment+ if cont for >7 d. Higher risk if DM/ CKD.
- Osteoporosis
- HIT (usually starts 5-10 d after treatment). monitor platelets before+ if >4 d
DOACs
Dabigatran - direct thrombin inhibitor (note bottles have a 4 month expiry)
Others -anti xa
Rarely cause bleeds.
Patient alert card
Take at same time of day, with full glass of water
If dose missed do NOT double next day
Avoid if antiphospholipid syndrome (not as effective as warfarin as per MHRA warning)
DOAC reversal agents
Dabigatran - praxbind (idarucizumab)
Apixaban+ rivaroxaban (ondexxya, andexanet alfa)
DOAC interactions (8)
https://hertsvalleysccg.nhs.uk/application
/files/1716/2340/3507/Drug_interactions_with
_NOACs_hmmc_june_2019_version_1.1.pdf
Strong inhibitors of p-gp or cyp3a4 increase the circulating levels of doacs
Many, so always check interactions
But the key key ones are:
1. Dronedarone
2. HIV protease inhibitors
3. Antifungals 4. Rifampicin
5. Antirejection agents (ciclosporin and tacrolimus)
6. AEDs (carbamazepine, phenytoin, phenobarbitone)
7. Antiplatelets (particulary prasugrel, ticagrelor)
8.St Johns wort
Also consider GI risk for NSAIDs, SSRIs, SNRIs
DOAC counselling
Patient alert card
Take at same time each day with a full glass of water
Do not double dose next day
Warfarin indications (3)
- Prophylaxis of a clot (rheumatic heart disease, AF, insertion prosthetic heart valve)
- Treatment of a VTE/ PE
- TIAs
Warfarin mode of action
Inhibits VKORC1 - which activates vit K. This menas warfarin depletes levels of FUNCTIONAL vit k and so reduces production of clotting factors.
Warfarin dosing: basics (dose, packet colors)
5mg starting dose. Test INR every 1-2 days. Maintenance 3-9mg. Same time every day. 0.5mg - white 1mg - brown 3mg - blue 5mg - pink
Warfarin dosing: duration of treatment (DVT, x2 VTE)
DVT in calf: 6 wks
VTE if provoked: 3 mths
VTE if unprovoked: 3mths + (long term considered)
Side effects of warfarin (2)
- Bleeding (phytomenadione)
2. Calciphylaxis (MHRA - report if painful skin rash)
Monitoring of warfarin
Once stable, 3monthly INR INR targets should be <1.1 in normal people 2.5 for most indications, except 3.5 for valve replacement or recurrent DVT/ PE
Warfarin toxicity
Bleeding
If major, stop warfarin give IV phytomenadione and dried prothrombin complex or fresh frozen plasma
Warfarin: food/ herbal/ drink interactions
Pomegranate, cranberry juice Alcohol (decreases w effect) Vitamin E Vitamin K St Johns Wort (decreases w effect)
Warfarin: drug interactions (serious) (6)
- Antibiotics (trimethoprim, co-trimoxazole, sulfonamides, metronidazole, rifampicin )
- Antifungals (miconazole - bleeding can take 15 days to develop. raised INR within 3 days., voriconazole)
- Antidiabetic drugs (glucagon)
- Antiepileptic drugs (carbamazepine, barbituates, primidone)
- Heart drugs (amiodarone, fibrates)
- Anticancer drugs/ hormones (anabolic steroids, tamoxifen, fluorouracil and prodrugs eg capcitabine, testosterone)
Warfarin: other key points (3)
- Counselling - take at same time each day, yellow book, alert card
2.MHRA warnings - calciphylaxis, RISK INCREASED IF CKD.
Direct acting antivirals to treat chornic hepatitis C - Warfarin in surgery - special requirements as per BNF (differs depending on whether elective or emergency)
What increases the risk of calciphylaxis in patients on warfarin?
CKD
Warfarin and elective surgery
If elective - stop 5 days before.
Give PO phytomenadione if INR >1.5 the day before
Restart warfarin the evening of surgery or the next day if all g
If high risk of clot, bridge with a LMWH. Stop it at least 24h before surgery. Do not restart LMWH untli at least 48 hours after surgery.
Warfarin and emergency surgery
Delay for 6-12h and give IV phytomenadione
If you can’t delay, give dried prothrombin complex+ phytomenadione. Check INR before surgery.
Treatment of haemorrhagic stroke longer term (2)
Treat HTN, avoid hypoperfusion
Avoid anticoag, aspirin, statins
Treatment of TIA
300mg aspirin for 14 days
Then onto clopidogrel 75mg OD long term (/ aspirin+ dipyridiamole/ aspirin)
+atorvastatin 80mg, HTN drug (But not a beta blocker)
HTN target <130/80
Treatment of ischaemic stroke
Alteplase within 4.5h
If no alteplase- aspirin within 48 hours
Then onto clopidogrel 75mg OD long term ( /aspirin+dipyridamole/ aspirin)
+atorvastatin 80mg, HTN drug (But not a beta blocker)
HTN target <130/80
What if the ischaemic stroke patient has AF?
Wait 2wks before anticoagulating - give aspirin before this.
Types of antiplatelets
- Aspirin
- Clopidogrel
- Dipyridamole (take 30-60 mins before and discard after 6 weeks)
- Glycoprotein IIa/IIb inhibitors
Stages of HTN
Normal: 120/80
Stage 1: 140/90 (135/85)
Stage 2: 160/100 (150/95)
Stage 3 (crisis): 180/110
What to do if at each stage of HTN
Stage 1 - only treat if meet 5 criteria
Stage 2 - always treat
Stage 3 - urgent IV (if target organ damage)/PO over 24-48h
5 criteria for treating stage 1 HTN (140/90 - 135/85) IF UNDER 80
If under 80…
- QRISK 20 or more
- Renal disease
- Diabetes
- CVD
- Target organ damage
Treatment pathway for HTN
If <55 - ACEI/ARB/ diabetes
If 55 or older/ afro-carribean: CCB
If failure, both together
If failure again, add in thiazide like diuretic
If failure again, more diuretic, alpha blokcer, beta blocker (but not with thiazide diuretic due to risk of hyperglycaemia)
BP targets
> 80: 150/90
Renal disease: 140/90 or 130/80 if CKD/ diabetes/ proteinuria >1g in 24h. consider ACEI or ARB if proteinuria present.
Pregnancy (chronic HTN): 150/90 or 140/90 if had birth or target organ damage
Diabetes: 140/80 or 130/80 if end target organ damage
Healthy: 140/90
Atherscleortic CVD: 130/80
Gestational diabetes
Target for chronic HTN: 150/90 or 140/90 if given birth/ target organ damage
Treatment options:
1. Labetalol is 1st line (hepatotoxic) but do NOT give in 1st trimester
2. Methyldopa (must stop 2 days after birth) - drowsiness and driving
3. M/R nifedipine (this is unlicensed)
Labetalol key points (3)
- 1st line
- Do NOT give in 1st trimester
- Is hepatotoxic
Methyldopa key points (3)
- Must stop 2 days after birth
- Drowsiness and driving
- 2nd line
Antihypertensives
- ACEIs
- ARBs
- CCBs
- Diuretics
- Alpha blockers (prazosin)
- Beta blockers
- Centrally acting - methyldopa, clonidine (flushing)
ACEI key points (3)
- Perindopril should be taken 30-60 minutes before food
- Captopril is only BD
- Take first dose at bedtime
+avoid in pregnancy
ACEI/ ARB side effects (6)
Dry cough due to build up of bradykinin (give ARB) Hyperkalemia Angiodema (anaphylaxis) Nephrotoxic Hepatic effects Hypoglycaemia
ACEI/ARB interactions (3)
- Hyperkalemia-k+ sparing diuretics
- Nephrotoxicity and reduced eGFR-nsaids
- Hypotension-diuretics
Intrinsic sympathomimetic activity beta blockers
PACO Pinodolo Acebutol Celiprolol Oxprenolol Mean that less bradycardia and less coldness of extremities
Water soluble beta blockers
Water CANS Celiprolol Atenolol Nadolol Sotalol Less likely to cross the BBB and so cause nightmares and sleep disturbance. REDUCE DOSE IN RENAL IMPAIRMENT.
Cardioselective beta blockers
Atenolol Acebutolol BISOPROLOL Nebivolol Metoprolol Cardioselective Less bronchospasm and so well controlled asthma under a specialist if no other choice
Beta blockers with an intrinsically long duration of action
BACoN Bisoprolol Atenolol Celiprolol Nadolol
Side effects of beta blocker (4)
- Bradycardia
- Cold peripheries
- Hypotension
- Masks symptoms of hypoglycaemia
Contraindications of beta blockers (4)
- Asthma (bronchospasm)
- Unstable heart failure
- 2nd/3rd degree heart block
- Severe hypotension and bradycardia
++++++++++caution if enzyme inhibitors as these increase Cp of beta blockers
Beta blockers interactions (2)
- Asystole+hypotension eg verapamil injection
2. Hyperglycaemia eg thiazide diuretics
Side effects of CCBs (3)
Ankle swelling
Flushing
Headaches
Rate limiting CCBs- key factors
Verapamil causes constipation
Diltiazem must maintain same brand when doses >60mg
Heart failure symptoms
Oedema (pulmonary-SOB, peripheral - swollen ankles or legs)
Dyspnoea (during activity/ at rest)
Fatigue/ exercise intolerance